The company behind Narcan looks toward a treatment for fentanyl ...
WEBMar 13, 2018 · A nasal spray designed to reverse opioid overdoses called Narcan has become a life-saving tool used by police departments and communities around the country. Now, the company that created Narcan – Opiant Pharmaceuticals (NSDQ: OPNT) – is hoping that its latest drug-device combination can …
Dexcom touts CGM studies, shares data on next-gen G7
WEBJune 3, 2021 By Sean Whooley. Dexcom (NSDQ:DXCM) today shared results from two studies of continuous glucose monitors, including its next-generation G7 CGM. San Diego-based Dexcom presented the studies during the 14th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD). The first study, the Mobile study, published ...
Xeris, Tetra Pharma enter $71M licensing agreement for glucagon ...
WEBJul 19, 2021 · Xeris Pharmaceuticals (NSDQ:XERS) announced today that it entered into an exclusive agreement with Tetris Pharma to commercialize Ogluo.. Chicago-based Xeris designed Ogluo (Gvoke PFS and Gvoke HypoPen in the U.S.) to be a ready-to-use, pre-mixed, pre-measured glucagon injection for treating severe hypoglycemia in adults, adolescents and children two years of age and older with diabetes mellitus.
NeuroRx completes merger with SPAC, starts trading on Nasdaq
WEBMay 25, 2021 By Sean Whooley. NeuroRx announced today that it commenced trading on the Nasdaq market following its merger with Big Rock Partners Acquisition Corp. The combined business entity will be known as NRx Pharmaceuticals and will trade on the Nasdaq market under the NRXP ticker, according to a news release.
Fresenius Kabi to acquire Ivenix and its smart infusion system for ...
WEBMar 31, 2022 · Fresenius Kabi announced today that it will acquire Ivenix with plans to bring a comprehensive infusion product portfolio to the U.S.. The acquisition, which has a purchase price of $240 million upfront, also includes potential milestone payments linked to achievements of commercial and operating targets.
J&J's Ethicon wins clearance for devices to deliver Grifols surgical ...
WEBJun 19, 2019 · Johnson & Johnson’s Ethicon has won FDA clearance for airless spray devices to deliver Grifols’ fibrin sealant to stop surgical bleeding, the companies announced today.
Insulin pens: Meet the insulin-makers and device companies
WEBMar 19, 2018 · Diamesco. This Koreo-based company has developed Pendiq, a digital insulin pen that can store a user’s last 1000 injections with the associated date, time and dose. The Bluetooth-enabled system is capable of dosing down to 0.1-unit amounts and delivers insulin using a motor-driven injection. Diamesco ‘s device has …
Vivani wants to bring a drug delivery implant to the diabetes market
WEBMar 1, 2023 · The company was developing a type 2 diabetes drug and a proprietary implant for delivery. Mendelsohn said that the six-month GLP-1-delivering implant was about twice the diameter and length of Vivani’s. Intarcia was once valued at more than $5 billion by investors. But despite the hype, the FDA refused to …
Stevanato, Bexson expand partnership for wearable drug delivery …
WEBApr 29, 2022 · Stevanato Group, Bexson expand partnership for wearable drug delivery device. April 29, 2022 By Sean Whooley. [Image from Stevanato Group] Stevanato Group and Bexson Biomedical announced today that they agreed to expand their drug delivery collaboration. Under the agreement, Bexson has access to the use of a customized version of Stevanato’s ...
Anika onshores manufacturing capabilities with new Bedford facility
WEBMay 23, 2017 By Sarah Faulkner. Anika Therapeutics (NSDQ: ANIK) opened a new global manufacturing facility today, on the same day that it celebrated the 25th anniversary of its Bedford, Mass.-based headquarters. Anika’s manufacturing operations were previously split between its U.S. headquarters and an Italy-based contract manufacturer.